Chapter 9 – Modulation of BACE1 Activity as a Potential Therapeutic Strategy for Treating Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-803959-5.50009-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1

  2012cited by this paper
• Structural plasticity upon learning: regulation and functions

  2012cited by this paper
• AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.

  2012cited by this paper
• ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches

  2012cited by this paper
• Control of BACE1 degradation and APP processing by ubiquitin carboxyl‐terminal hydrolase L1

  2012cited by this paper
• Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons

  2012cited by this paper
• Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo*

  2012cited by this paper
• Nonsteroidal anti‐inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease

  2012cited by this paper
• Immune Regulation by Sphingosine 1-Phosphate and Its Receptors

  2012cited by this paper
• BACE1 in central nervous system myelination revisited

  2012cited by this paper
• The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

  2012cited by this paper
• Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant

  2012cited by this paper
• Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.

  2012cited by this paper
• MicroRNAs in neurodegenerative diseases and their therapeutic potential.

  2012cited by this paper
• A G‐Rich element forms a G‐quadruplex and regulates BACE1 mRNA alternative splicing

  2012cited by this paper
• The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb

  2011cited by this paper
• Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease

  2011cited by this paper
• BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate

  2011cited by this paper
• Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target

  2011cited by this paper
• A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

  2011cited by this paper
• Functions of Noncoding RNAs in Neural Development and Neurological Diseases

  2011cited by this paper
• miR-29c regulates BACE1 protein expression.

  2011cited by this paper
• Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.

  2011cited by this paper
• Inhibition of β-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1*

  2011cited by this paper
• K63-linked ubiquitination and neurodegeneration.

  2011cited by this paper
• The outs and the ins of sphingosine-1-phosphate in immunity

  2011cited by this paper
• Gerstmann–Sträussler–Scheinker Disease

  2011cited by this paper
• Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

  2011cited by this paper
• Efficacy of PPAR-agonist pioglitazone in mild Alzheimer disease

  2011cited by this paper
• Effects of Heparin and Enoxaparin on APP Processing and Aβ Production in Primary Cortical Neurons from Tg2576 Mice

  2011cited by this paper
• MicroRNAs in brain development and degeneration

  2011cited by this paper
• Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic mice

  2010cited by this paper
• In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

  2010cited by this paper
• Structural design, solid-phase synthesis and activity of membrane-anchored β-secretase inhibitors on Aβ generation from wild-type and Swedish-mutant APP.

  2010cited by this paper
• BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration

  2010cited by this paper
• Widespread distribution of reticulon‐3 in various neurodegenerative diseases

  2010cited by this paper
• Glycosaminoglycan‐induced activation of the β‐secretase (BACE1) of Alzheimer’s disease

  2010cited by this paper
• Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease*

  2010cited by this paper
• SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2

  2010cited by this paper
• Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

  2010cited by this paper
• Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions

  2010cited by this paper
• Structural and thermodynamic characteristics of the exosite binding pocket on the human BACE1: a molecular modeling approach.

  2010cited by this paper
• MiR-107 is Reduced in Alzheimer's Disease Brain Neocortex: Validation Study

  2010cited by this paper
• Ubiquitin Regulates GGA3-mediated Degradation of BACE1*

  2010cited by this paper
• Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX-2 Inhibitors the Next Line of Therapy?

  2010cited by this paper
• RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model

  2009cited by this paper
• MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1*

  2009cited by this paper
• Expression of reticulon 3 in Alzheimer's disease brain

  2009cited by this paper
• Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts*

  2009cited by this paper
• Reduced Amyloid Deposition in Mice Overexpressing RTN3 Is Adversely Affected by Preformed Dystrophic Neurites

  2009cited by this paper
• Dysregulation of Calcium Homeostasis in Alzheimer’s Disease

  2009cited by this paper
• Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM.

  2009cited by this paper
• Boom in the development of non‐peptidic β‐secretase (BACE1) inhibitors for the treatment of Alzheimer's disease

  2009cited by this paper
• Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

  2009cited by this paper
• The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease

  2009cited by this paper
• RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

  2009cited by this paper
• PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS

  2009cited by this paper
• Calcium enhances the proteolytic activity of BACE1: An in vitro biophysical and biochemical characterization of the BACE1-calcium interaction.

  2009cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cited by this paper
• Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

  2008cited by this paper
• Promotion of BACE1 mRNA Alternative Splicing Reduces Amyloid β-Peptide Production*

  2008cited by this paper
• Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.

  2008cited by this paper
• Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling

  2008cited by this paper
• A Modern Hypothesis: The Distinct Pathologies of Dementia Associated with Parkinson’s Disease versus Alzheimer’s Disease

  2008cited by this paper
• Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves

  2008cited by this paper
• The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2008cited by this paper
• Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting

  2008cited by this paper
• Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules.

  2008cited by this paper
• Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase

  2008cited by this paper
• Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

  2007cited by this paper
• Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice*

  2007cited by this paper
• Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities

  2007cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007cited by this paper
• Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides

  2007cited by this paper
• Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

  2007cited by this paper
• Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor*

  2007cited by this paper
• BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.

  2007cited by this paper
• BACE1 regulates voltage-gated sodium channels and neuronal activity

  2007cited by this paper
• Mapping of interaction domains mediating binding between BACE1 and RTN/Nogo proteins.

  2006cited by this paper
• Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

  2006cited by this paper
• Neuregulin 1–erbB Signaling Is Necessary for Normal Myelination and Sensory Function

  2006cited by this paper
• Heparin activates beta-secretase (BACE1) of Alzheimer's disease and increases autocatalysis of the enzyme.

  2006cited by this paper
• GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid β-Peptide

  2006cited by this paper
• GGA1 Acts as a Spatial Switch Altering Amyloid Precursor Protein Trafficking and Processing

  2006cited by this paper
• Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study

  2006cited by this paper
• Bace1 modulates myelination in the central and peripheral nervous system

  2006cited by this paper
• Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.

  2006cited by this paper
• Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

  2006cited by this paper
• Left insular stroke is associated with adverse cardiac outcome

  2006cited by this paper
• Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1

  2006cited by this paper
• Reticulons RTN3 and RTN4‐B/C interact with BACE1 and inhibit its ability to produce amyloid β‐protein

  2006cited by this paper
• BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions

  2005cited by this paper
• SCN1A mutations and epilepsy

  2005cited by this paper
• GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network.

  2005cited by this paper
• GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)*

  2005cited by this paper
• An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.

  2005cited by this paper
• Nonsteroidal anti-inflammatory drugs repress (cid:1) -secretase gene promoter activity by the activation of PPAR (cid:2)

  2005cited by this paper
• First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early‐onset Alzheimer's disease: Comparison with senile dementia of Alzheimer's type

  2005cited by this paper
• BACE Is Degraded via the Lysosomal Pathway*

  2005cited by this paper

• Role of BACE1 in Cognitive Function, from Alzheimer’s Disease to Traumatic Brain Injury

  2016cites this paper